An experimental treatment by Pfizer and Arvinas delayed progression of breast cancer by more than three months compared to ...

Regeneron shares fell nearly 13% before the bell on Friday after its experimental drug for patients with a type of lung ...

(Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of lung condition ...

Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Set to enter larger trial across 5 countries, it works by permanently turning off gene that causes high bad cholesterol ...

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in ...

Sanofi and Regeneron said that drug candidate Itepekimab didn’t meet primary endpoint in a phase three study, although a ...

EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for ...

Merck's ( NYSE: MRK) experimental antibody drug conjugate zilovertamab vedotin, in combination with standard of care, ...

US FDA grants fast track designation to EDDC’s antibody-drug conjugate EBC-129 to treat pancreatic ductal adenocarcinoma: Singapore Thursday, May 29, 2025, 12:00 Hrs [IST] The E ...